Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
January 7th, 2026
Don’t Let These Privacy Shifts Blindside You In 2026
AdExchanger quoted Holly Melton in an article examining the significant privacy and regulatory shifts expected to reshape the digital advertising landscape in 2026. Ms. Melton discussed the growing impact of youth privacy and age‑assurance laws, noting that new state regulations are effectively requiring advertisers to treat all users as potentially under 18 unless age can be reliably verified. She explained that this shift will be especially challenging for brands in sectors with large teen audiences—such as beauty, fashion, gaming, and entertainment—many of which have never had to operate under youth‑marketing standards. Ms. Melton emphasized that these developments signal a broader regulatory trend, stating that “the biggest blind spot for many advertisers is assuming these youth‑focused rules won’t apply to them.” She advised that companies begin preparing now by reassessing data practices, strengthening compliance frameworks, and ensuring that youth‑directed content and targeting meet emerging legal expectations. Read the full article on upcoming privacy changes here.
Other Quoted
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
What Cannes Lions Can Teach Us About Advertising’s Most Important Customer
Cannes Lions brought important conversations to the stage about advertising’s most important stakeholder: the public. Read more.
July 2 2026
